AU610174B2 - Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method - Google Patents

Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method

Info

Publication number
AU610174B2
AU610174B2 AU16502/88A AU1650288A AU610174B2 AU 610174 B2 AU610174 B2 AU 610174B2 AU 16502/88 A AU16502/88 A AU 16502/88A AU 1650288 A AU1650288 A AU 1650288A AU 610174 B2 AU610174 B2 AU 610174B2
Authority
AU
Australia
Prior art keywords
phosphorus
coa reductase
reductase inhibitors
new intermediates
containing hmg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU16502/88A
Other languages
English (en)
Other versions
AU1650288A (en
Inventor
Michael Christopher Badia
Scott Adams Biller
Eric Michael Gordon
Donald Steven Karanewsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of AU1650288A publication Critical patent/AU1650288A/en
Application granted granted Critical
Publication of AU610174B2 publication Critical patent/AU610174B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/303—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3241—Esters of arylalkanephosphinic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU16502/88A 1987-05-22 1988-05-20 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method Ceased AU610174B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5323887A 1987-05-22 1987-05-22
US10968187A 1987-10-19 1987-10-19
US109681 1987-10-19
US053238 1993-04-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU71266/91A Division AU643501B2 (en) 1987-05-22 1991-02-21 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method

Publications (2)

Publication Number Publication Date
AU1650288A AU1650288A (en) 1988-11-24
AU610174B2 true AU610174B2 (en) 1991-05-16

Family

ID=26731613

Family Applications (2)

Application Number Title Priority Date Filing Date
AU16502/88A Ceased AU610174B2 (en) 1987-05-22 1988-05-20 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
AU71266/91A Ceased AU643501B2 (en) 1987-05-22 1991-02-21 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU71266/91A Ceased AU643501B2 (en) 1987-05-22 1991-02-21 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method

Country Status (24)

Country Link
JP (1) JPH01139589A (fi)
KR (1) KR880013959A (fi)
CN (1) CN1030761A (fi)
AU (2) AU610174B2 (fi)
BE (1) BE1002251A3 (fi)
CH (3) CH675582A5 (fi)
DE (1) DE3817298C2 (fi)
DK (1) DK277388A (fi)
ES (1) ES2009919A6 (fi)
FI (1) FI87927C (fi)
FR (1) FR2615516B1 (fi)
GB (1) GB2205838B (fi)
GR (1) GR880100332A (fi)
HU (1) HU201085B (fi)
IE (1) IE63715B1 (fi)
IL (1) IL86463A (fi)
IT (1) IT1217684B (fi)
NL (1) NL8801331A (fi)
NO (1) NO882219L (fi)
NZ (1) NZ224734A (fi)
PH (2) PH25581A (fi)
PL (1) PL157761B1 (fi)
PT (1) PT87540B (fi)
SE (3) SE501541C2 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2009918A6 (es) * 1987-05-22 1989-10-16 Squibb & Sons Inc Procedimiento para preparar inhibidores de hmg-coa-reductasa que contienen fosforo.
JPH03184961A (ja) * 1989-10-10 1991-08-12 Glaxo Group Ltd 化合物
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
CA2042526A1 (en) * 1990-06-11 1991-12-12 Adeoye Y. Olukotun Method for preventing a second heart attack employing an hmg coa reductase inhibitor
CA2043525A1 (en) * 1990-06-24 1991-12-25 Donald S. Karanewsky Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
DE4023308A1 (de) * 1990-07-21 1992-01-23 Bayer Ag Substituierte pyrido-oxazine
DE4025818A1 (de) * 1990-08-16 1992-02-20 Bayer Ag Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate
NZ241574A (en) * 1991-02-22 1993-08-26 Ishihara Sangyo Kaisha Substituted phenyl derivatives of hydrazone and pesticidal compositions
US5202327A (en) * 1991-07-10 1993-04-13 E. R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors
US5256692A (en) * 1992-01-07 1993-10-26 E. R. Squibb & Sons, Inc. Sulfur-containing HMG-COA reductase inhibitors
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
AU2003218758A1 (en) * 2002-03-14 2003-09-22 Syngenta Participations Ag Derivatives of 1-phenyl-3-phenylpyrazole as herbicides
JP4407237B2 (ja) * 2002-12-24 2010-02-03 三菱化学株式会社 非水系電解液及びそれを用いる非水系電解液二次電池
JP4485169B2 (ja) 2003-05-16 2010-06-16 花王株式会社 腸管ミネラル吸収能改善剤
CN1760363B (zh) * 2004-10-14 2010-04-28 蒋继宏 杜仲3-羟基-3-甲基戊二酰辅酶a还原酶蛋白编码序列
WO2007081019A1 (ja) * 2006-01-16 2007-07-19 Sankyo Agro Company, Limited （３－硫黄原子置換フェニル）ピラゾール誘導体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1650888A (en) * 1987-05-22 1988-11-24 E.R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR339233A (fr) * 1903-12-23 1905-01-26 Cyanidgesellschaft Mit Beschra Nouveau procédé pour l'obtention d'explosifs
DE803645C (de) * 1949-10-11 1951-04-05 Dynamit Act Ges Vormals Alfred Schagwettersichere Sprengkapsel in Verbindung mit elektrischen Zuendern
DE918196C (de) * 1952-12-23 1954-09-20 J G W Berckholtz Fa Masse zur Erzeugung von farbigem Rauch
US3274035A (en) * 1964-06-15 1966-09-20 Lohr A Burkardt Metallic composition for production of hygroscopic smoke
US3862866A (en) * 1971-08-02 1975-01-28 Specialty Products Dev Corp Gas generator composition and method
DE2841815C2 (de) * 1978-09-26 1985-02-21 Buck Chemisch-Technische Werke GmbH & Co, 7347 Bad Überkingen Verfahren zur Herstellung einer Geschoßfüllung
US4438700A (en) * 1982-07-19 1984-03-27 The United States Of America As Represented By The Secretary Of The Army White smoke spotting composition for training ammunition
FR2596393B1 (fr) * 1986-04-01 1988-06-03 Sanofi Sa Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1650888A (en) * 1987-05-22 1988-11-24 E.R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method

Also Published As

Publication number Publication date
KR880013959A (ko) 1988-12-22
NO882219L (no) 1988-11-23
CH678625A5 (fi) 1991-10-15
PT87540A (pt) 1989-05-31
IE881544L (en) 1988-11-22
IE63715B1 (en) 1995-06-14
DK277388A (da) 1988-11-23
CH678626A5 (fi) 1991-10-15
FR2615516A1 (fr) 1988-11-25
FI882385A (fi) 1988-11-23
HU201085B (en) 1990-09-28
FR2615516B1 (fr) 1991-04-12
AU643501B2 (en) 1993-11-18
IT1217684B (it) 1990-03-30
GB8811931D0 (en) 1988-06-22
PH25581A (en) 1991-08-08
FI87927B (fi) 1992-11-30
CH675582A5 (fi) 1990-10-15
PT87540B (pt) 1992-09-30
BE1002251A3 (fr) 1990-11-06
IT8820681A0 (it) 1988-05-20
NZ224734A (en) 1991-04-26
DE3817298C2 (de) 1997-02-13
IL86463A0 (en) 1988-11-15
PH26578A (en) 1992-08-19
FI87927C (fi) 1993-03-10
IL86463A (en) 1994-10-07
AU7126691A (en) 1991-05-02
AU1650288A (en) 1988-11-24
CN1030761A (zh) 1989-02-01
HUT47123A (en) 1989-01-30
SE8801904D0 (sv) 1988-05-20
DK277388D0 (da) 1988-05-20
SE9201588A0 (sv) 1992-05-20
SE9201587A0 (sv) 1992-05-14
SE9201587D0 (sv) 1992-05-20
PL157761B1 (pl) 1992-06-30
GB2205838B (en) 1991-12-11
SE8801904L (sv) 1988-11-23
SE9201588D0 (sv) 1992-05-20
DE3817298A1 (de) 1988-12-01
GR880100332A (el) 1989-02-23
NL8801331A (nl) 1988-12-16
NO882219D0 (no) 1988-05-20
GB2205838A (en) 1988-12-21
SE501541C2 (sv) 1995-03-06
JPH01139589A (ja) 1989-06-01
FI882385A0 (fi) 1988-05-20
ES2009919A6 (es) 1989-10-16

Similar Documents

Publication Publication Date Title
AU610591B2 (en) Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
AU6084686A (en) Novel hmg-coa reductase inhibitors
AU643501B2 (en) Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
JPS6426535A (en) Novel hmg-coa reductase inhibitor
AU3106197A (en) Cytokine production inhibitors, triazepine compounds, and intermediates there of
AU5533094A (en) Enzyme inhibitors
AU6527090A (en) Substituted cyclohexene derivatives as hmg-coa reductase inhibitors
AU2058992A (en) HMG-COA reductase inhibitors
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
AU6205990A (en) Cold-rolled steel sheet for deep drawings and method of producing the same
AU2175088A (en) Novel hmg-coa reductase inhibitors
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
GB2235924B (en) Phosphorus-containing hmg-coa reductase inhibitors,new intermediates and method
GB2238545B (en) Phosphorus-containing hmg-coa reductase inhibitors,new intermediates and method
ZA883621B (en) Phosphorus-containing hmg-coa reductase inhibitors,new intermediates and method
ZA883620B (en) Phosphorus-containing hmg-coa reductase inhibitors,new intermediates and methods
EP0283123A3 (en) Intermediates and process useful in the preparation of hmg-coa reductase inhibitors
EP0306263A3 (en) Novel hmg-coa reductase inhibitors
EP0468974A4 (en) Novel hmg-coa reductase inhibitors
ZA874487B (en) Novel hmg-coa reductase inhibitors
IE871654L (en) Novel hmg-coa reductase inhibitors
AU2459297A (en) Method of preparing phosphodiesterase iv inhibitors
IE851368L (en) Preparing hmg-coa reductase inhibitors
IE861739L (en) Hmg-coa reductase inhibitors
IE822652L (en) HMG-CoA REDUCTASE INHIBITORS